Sandoz Group AG Stock
Sandoz Group AG took a tumble today and lost -€2.460 (-3.090%).
Pros and Cons of Sandoz Group AG in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
News
Sandoz delivers strong full-year results; guidance for 2026 reflects an expected acceleration in growth
Sandoz delivers strong full-year results; guidance for 2026 reflects an expected acceleration in growth
Sandoz confirms European Commission approval for Ranluspec® (ranibizumab), further strengthening overall biosimilars leadership and position in ophthalmology
Sandoz confirms European Commission approval for Ranluspec® (ranibizumab), further strengthening overall biosimilars leadership and position in ophthalmology
Sandoz receives US FDA approval to expand Enzeevu® (aflibercept-abzv) label for multiple retinal indications
Sandoz receives US FDA approval to expand Enzeevu® (aflibercept-abzv) label for multiple retinal indications